BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36863606)

  • 1. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
    Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
    Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
    Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin analog initiation therapy on LDL/HDL subfraction profile and HDL associated enzymes in type 2 diabetic patients.
    Aslan I; Kucuksayan E; Aslan M
    Lipids Health Dis; 2013 Apr; 12():54. PubMed ID: 23617853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy.
    Özer H; Aslan İ; Oruç MT; Çöpelci Y; Afşar E; Kaya S; Aslan M
    Lipids Health Dis; 2018 Nov; 17(1):269. PubMed ID: 30474555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.
    Ozturk OH; Can Y; Yonden Z; Motor S; Oktay G; Kaya H; Aslan M
    Lipids; 2013 Dec; 48(12):1217-26. PubMed ID: 24113910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelins and ceramides: possible biomarkers for dementia?
    Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
    Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Sphingolipids in Pediatric Patients with Cholelithiasis-A Preliminary Study.
    Zdanowicz K; Bobrus-Chcociej A; Pogodzinska K; Blachnio-Zabielska A; Zelazowska-Rutkowska B; Lebensztejn DM; Daniluk U
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherogenic role of elevated CE transfer from HDL to VLDL(1) and dense LDL in type 2 diabetes : impact of the degree of triglyceridemia.
    Guérin M; Le Goff W; Lassel TS; Van Tol A; Steiner G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2001 Feb; 21(2):282-8. PubMed ID: 11156866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postoperative changes of HDL subfraction profile and HDL-associated enzymes after laparoscopic sleeve gastrectomy.
    Doğan S; Aslan I; Eryılmaz R; Ensari CO; Bilecik T; Aslan M
    Obes Surg; 2013 Dec; 23(12):1973-80. PubMed ID: 23760763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
    Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
    Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood sphingolipidomics in healthy humans: impact of sample collection methodology.
    Hammad SM; Pierce JS; Soodavar F; Smith KJ; Al Gadban MM; Rembiesa B; Klein RL; Hannun YA; Bielawski J; Bielawska A
    J Lipid Res; 2010 Oct; 51(10):3074-87. PubMed ID: 20660127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the Distribution of Ceramides and Sphingosine among Lipoprotein and Lipoprotein-Depleted Fractions in Patients with Type 2 Diabetes Mellitus.
    Kurano M; Tsukamoto K; Sakai E; Yatomi Y
    J Atheroscler Thromb; 2022 Dec; 29(12):1727-1758. PubMed ID: 35082227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant abnormalities of the HDL phosphosphingolipidome in type 1 diabetes despite normal HDL cholesterol concentration.
    Denimal D; Pais de Barros JP; Petit JM; Bouillet B; Vergès B; Duvillard L
    Atherosclerosis; 2015 Aug; 241(2):752-60. PubMed ID: 26142685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of multiple lipid and lipoprotein ratios with nonalcoholic fatty liver disease in patients with newly diagnosed type 2 diabetic mellitus: A retrospective study.
    Li R; Kong D; Ye Z; Zong G; Hu K; Xu W; Fang P; Zhang L; Zhou Y; Zhang K; Xue Y
    Front Endocrinol (Lausanne); 2023; 14():1127134. PubMed ID: 36875464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.
    Ståhlman M; Fagerberg B; Adiels M; Ekroos K; Chapman JM; Kontush A; Borén J
    Biochim Biophys Acta; 2013 Nov; 1831(11):1609-17. PubMed ID: 23896361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.
    Le Barz M; Vors C; Combe E; Joumard-Cubizolles L; Lecomte M; Joffre F; Trauchessec M; Pesenti S; Loizon E; Breyton AE; Meugnier E; Bertrand K; Drai J; Robert C; Durand A; Cuerq C; Gaborit P; Leconte N; Bernalier-Donadille A; Cotte E; Laville M; Lambert-Porcheron S; Ouchchane L; Vidal H; Malpuech-Brugère C; Cheillan D; Michalski MC
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33857018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fatty acids of sphingomyelins and ceramides in mammalian tissues and cultured cells: Biophysical and physiological implications.
    Manni MM; Sot J; Arretxe E; Gil-Redondo R; Falcón-Pérez JM; Balgoma D; Alonso C; Goñi FM; Alonso A
    Chem Phys Lipids; 2018 Dec; 217():29-34. PubMed ID: 30359584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.